What is Solventum's D&A?

Solventum (SOLV) reported D&A of $135M in Q1 2026.

How has Solventum's D&A changed year-over-year?

Solventum's D&A increased by 4.7% year-over-year, from $129M to $135M.

What is the long-term trend for Solventum's D&A?

Over 3 years (2022 to 2025), Solventum's D&A has grown at a -5.4% compound annual growth rate (CAGR), from $578M to $489M.

Solventum SOLV D&A

D&A at other companies

3MMMM

$326M+12.4%

UnitedHealth GroupUNH

$1.03B-3.0%

Globus MedicalGMED

$29.53M-55.3%

Baxter InternationalBAX

$237M-4.0%

Medline, Inc. MDLN

$254M+2.8%

GE HealthCare TechnologiesGEHC

——

Other financials

Income statement

See full

Revenue$2.0B-3.0%

Gross profit$1.1B-1.5%

Operating income$81.0M-46.7%

Net income$13.0M-90.5%

EPS (diluted)$0.07-91.0%

Balance sheet

See full

Cash & equivalents$561.0M+5.1%

Total debt$5.8B-26.8%

Total equity$5.0B+52.3%

Total assets$14.1B-3.0%

Cash flow

See full

Operating cash flow-$189.0M-752%

CapEx$84.0M-22.9%

Free cash flow-$273.0M-241%

Valuation

See full

Market cap$13.06B-13.9%

Enterprise value$18.29B-19.4%

P/E9.1×-30.9×

P/S1.6×-0.2×

Profitability

See full

Gross margin53.7%-0.9pp

Operating margin25.5%+15.8pp

Net margin17.3%+12.8pp

FCF margin4.6%-13.9pp

Returns & leverage

See full

Return on equity34.8%+24.1pp

Debt / equity1.2×-1.3×

Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solventum's D&A?: Solventum (SOLV) reported D&A of $135M in Q1 2026.
How has Solventum's D&A changed year-over-year?: Solventum's D&A increased by 4.7% year-over-year, from $129M to $135M.
What is the long-term trend for Solventum's D&A?: Over 3 years (2022 to 2025), Solventum's D&A has grown at a -5.4% compound annual growth rate (CAGR), from $578M to $489M.